Real Estate Healthcare Sector

Wellgistics Health

Market Cap: US$165.1m

Engages in the wholesale and distribution of pharmaceutical products to pharmaceutical manufacturers and independent retail pharmacies in the United States.

Tiziana Life Sciences

Market Cap: US$165.0m

A biotechnology company, specializes in the development of transformative therapies for neurodegenerative and lung diseases in the United States.

Inogen

Market Cap: US$164.8m

A medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally.

TuHURA Biosciences

Market Cap: US$164.7m

A clinical stage immuno-oncology company, that develops novel technologies for the treatment of cancer immunotherapies.

Liminatus Pharma

Market Cap: US$163.9m

Operates as a clinical-stage immuno-oncology company that develops novel cancer therapies.

Procaps Group

Market Cap: US$163.6m

Develops, produces, and markets pharmaceutical solutions worldwide.

Alpha Cognition

Market Cap: US$160.2m

A biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada.

AFT Pharmaceuticals

Market Cap: NZ$270.6m

Engages in the development and sale of pharmaceutical products in New Zealand, Australia, Asia, and internationally.

hVIVO

Market Cap: UK£119.1m

Operates as a pharmaceutical service and contract research company in the United Kingdom, Europe, and North America.

SELLAS Life Sciences Group

Market Cap: US$159.0m

A late-stage clinical biopharmaceutical company, focuses on the development of novel therapeutics for various cancer indications in the United States.

Journey Medical

Market Cap: US$159.0m

Focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.

Cybin

Market Cap: US$157.8m

A clinical-stage biopharmaceutical company, focuses on developing psychedelic-based therapeutics for patients with mental health conditions.

EKF Diagnostics Holdings

Market Cap: UK£117.3m

Engages in the design, development, manufacture, and sale of diagnostic instruments, reagents, and other ancillary products in the Americas, Europe, the Middle East, Asia, Africa, and internationally.

Avacta Group

Market Cap: UK£115.0m

Develops cancer drugs and in vitro diagnostics in the United Kingdom, France, North America, South Korea, rest of Europe, and internationally.

Joint

Market Cap: US$153.9m

Operates and franchises chiropractic clinics in the United States.

Race Oncology

Market Cap: AU$238.0m

A clinical stage biopharmaceutical company, focuses on addressing the unmet needs of cancer patients for damaging treatments.

Diaceutics

Market Cap: UK£113.7m

A diagnostic commercialisation company, provides data, data analytics, and implementation services for pharmaceutical companies worldwide.

Longduoduo

Market Cap: US$149.8m

Together its subsidiaries, provides preventive healthcare solutions in the People’s Republic of China.

Korro Bio

Market Cap: US$147.5m

A biopharmaceutical company, engages in the discovering, developing, and commercializing of genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases in the United States.

Anteris Technologies Global

Market Cap: AU$227.6m

A structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases.

Cogstate

Market Cap: AU$226.2m

A neuroscience technology company, engages in the creation, validation, and commercialization of digital brain health assessments used in both academic and industry sponsored research.

Aldeyra Therapeutics

Market Cap: US$144.9m

A biotechnology company, discovers and develops therapies designed to treat immune-mediated and metabolic diseases.

EUDA Health Holdings

Market Cap: US$144.2m

Operates as a healthcare specialty company.

DocGo

Market Cap: US$143.7m

Provides mobile health and medical transportation services in the United States and the United Kingdom.

Profound Medical

Market Cap: CA$199.3m

Operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland.

Rapid Micro Biosystems

Market Cap: US$143.1m

A life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally.

NeOnc Technologies Holdings

Market Cap: US$141.4m

A clinical-stage biopharmaceutical company, focuses on developing treatments for intracranial malignancies.

BioAge Labs

Market Cap: US$141.2m

A biopharmaceutical company that develops therapeutic product candidates for metabolic diseases.

Pro-Dex

Market Cap: US$141.0m

Designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide.

Aclaris Therapeutics

Market Cap: US$140.8m

A clinical-stage biopharmaceutical company, engages in the development of novel drug candidates for immune-inflammatory diseases in the United States.

Global Cord Blood

Market Cap: US$140.6m

Provides umbilical cord blood storage and ancillary services in the People's Republic of China.

Fate Therapeutics

Market Cap: US$139.9m

A clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders in the United States and internationally.

Inhibikase Therapeutics

Market Cap: US$139.0m

Operates as a clinical-stage pharmaceutical company that develops therapeutics for Parkinson’s disease and related disorders.

Exagen

Market Cap: US$138.3m

Designs, develops, and commercializes various testing products under the AVISE brand in the United States.

Eupraxia Pharmaceuticals

Market Cap: CA$191.8m

A clinical-stage biotechnology company, engages in the discovery, development, and marketing of technologies in the biotechnology sector.

KORU Medical Systems

Market Cap: US$137.0m

Develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally.